Low concentration of hyaluronidase for oocyte denudation can improve fertilization rates and embryo quality
- PMID: 28333029
- PMCID: PMC5365197
- DOI: 10.5935/1518-0557.20170008
Low concentration of hyaluronidase for oocyte denudation can improve fertilization rates and embryo quality
Abstract
Objective: Hyaluronidase enzyme is an extremely important factor for the process of oocyte denudation, but little is known about its negative effects.
Methods: This prospective randomized study analyzed the results of using different concentrations of hyaluronidase (Diluted: 8IU/mL and Normal: 80IU/mL) used for denudation of sibling-oocytes for 22 women undergoing treatment for assisted reproduction by ICSI. A total of 192 oocytes were injected, being 104 for group I (diluted) and 88 for group II (normal). We analyzed fertilization rate, cleavage, embryo quality at 48 and 72 hours and number of transferred embryos in each group.
Results: The diluted enzyme group showed better results in fertilization rates (92.3% vs. 80.6%), mean cleavage (4.18 ± 2.57 vs. 3.09 ± 1.90), in 48-hour embryos A and A + B (60.9% vs. 44.1% and 90.2% vs. 82.3%) and at 72 hours (45.6% vs. 36.8% and 77.1% vs 66.2%), and number of embryos selected for transfer (61.8% vs. 38.1%). The overall pregnancy rate was 59.1%.
Conclusion: This study demonstrates that the use of 8 IU/mL of hyaluronidase, according to the following protocol, is beneficial and can be successfully used for oocyte denudation, and it is also economically advantageous to the laboratory.
Keywords: Hyaluronidase; ICSI; cumulus- oocyte complex; oocyte denudation.
References
-
- Abdelmassih R, Sollia S, Moretto M, Acosta AA. Female age is an important parameter to predict treatment outcome in intracytoplasmic sperm injection. Fertil Steril. 1996;65:573–577. http://dx.doi.org/10.1016/S0015-0282(16)58156-4 - DOI - PubMed
-
- Abramczuk JW, Lopata A. Resistance of human follicular oocytes to parthenogenetic activation: DNA distribution and content in oocytes maintained in vitro. Hum Reprod. 1990;5:578–581. http://dx.doi.org/10.1093/oxfordjournals.humrep.a137148 - DOI - PubMed
-
- De Vos A, Van Landuyt L, Van Ranst H, Vandermonde A, D'Haese V, Sterckx J, Haentjens P, Devroey P, Van der Elst J. Randomized sibling-oocyte study using recombinant human hyaluronidase versus bovine derived Sigma hyaluronidase in ICSI patients. Hum Reprod. 2008;23:1815–1819. http://dx.doi.org/10.1093/humrep/den212 - DOI - PubMed
-
- Dozortsev D, Nagy P, Abdelmassih S, Oliveira F, Brasil A, Abdelmassih V, Diamond M, Abdelmassih R. The optimal time for intracytoplasmic sperm injection in the human is from 37 to 41 hours after administration of human chorionic gonadotropin. Fertil Steril. 2004;82:1492–1496. http://dx.doi.org/10.1016/j.fertnstert.2004.09.002 - DOI - PubMed
-
- Ebner T, Moser M, Sommergruber M, Shebl O, Tews G. Incomplete denudation of oocytes prior to ICSI enhances embryo quality and blastocyst development. Hum Reprod. 2006;21:2972–2977. http://dx.doi.org/10.1093/humrep/del272 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
